Vertex Pharmaceuticals

#Breaking: The U.S. FDA has approved our newest treatment for cystic fibrosis (CF). This milestone marks our fifth approved therapy for CF, reflecting our commitment to people living with CF. Learn more: https://lnkd.in/eB7QH_sF

#Breaking: The U.S. FDA approves a label extension for #CysticFibrosis. We are excited to make this treatment available to more eligible patients. Learn more: https://www.vrtx.com/

Creating the future of cystic fibrosis (CF) treatment takes teamwork. Sabine Hadida, SVP and head of our San Diego research site, shares how Vertex’s journey in CF relies on patients' insights every step of the way. https://lnkd.in/eyAaerUz

Innovation at Vertex is driven by a single purpose: to transform lives. Our Vertex Fellows program is a unique, one-year opportunity that brings together the best and the brightest of the next generation of scientists and physicians from around the globe — and applications are now open. Vertex Fellows collaborate with project teams and make real world contributions to serious diseases and patient communities. Turn your potential into progression — learn more about the program and apply by January 10. https://lnkd.in/eNsYGBQj

For many, living with type 1 diabetes (T1D) means living with the fear associated with the severe high and low blood sugars they may experience due to this disease. Listen to what those times can feel like.

When a routine call turned into a mayday situation, firefighter Cody Burton’s knowledge of the complexities of pain management became even more important. Hear how Cody navigated weeks of severe pain following his injury and why being prepared to discuss pain management with your doctor can be crucial: https://lnkd.in/ePFSqSDt

Collaborating with other researchers and professionals working in the hematology space at the American Society of Hematology annual meeting reinforced our commitment to having a transformative impact on the lives of patients. As we continue to advance our sickle cell disease and beta thalassemia programs, hearing and learning from others who share our goals was a wonderful experience.

We’re committed to the sickle cell community in everything we do. Beyond our science, we’re working together with sickle cell warriors, caregivers and physicians to empower meaningful change. We are with you. Learn more: https://bit.ly/4g6WQp4

Congratulations to our Boston Research-Biology Team for their efforts earning them the Top Biopharma Laboratory Award in the International Freezer Challenge organized by My Green Lab and the International Institute for Sustainable Laboratories. This challenge encourages organizations to keep good maintenance of biological samples in an effort to protect our planet. The team’s cleanup process led to an estimated 437.75 kWh/day in energy savings, equivalent to the energy produced by 14 American households each day! Learn more about the challenge: https://lnkd.in/gC8jPbW8

At the American Society of Hematology (ASH) Annual Meeting this weekend, we are pleased to share new data on our gene-edited therapy. Learn more: https://lnkd.in/ej2E6QWb